Literature DB >> 34484955

Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset.

Reiji Aoki1, Masahiro Mori1, Yo-Ichi Suzuki1, Akiyuki Uzawa1, Hiroki Masuda1, Tomohiko Uchida1, Ryohei Ohtani1, Satoshi Kuwabara1.   

Abstract

Entities:  

Year:  2021        PMID： 34484955      PMCID： PMC8382410          DOI： 10.1212/CPJ.0000000000001051

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

1.  Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.

Authors:  DeRen Huang
Journal:  Neurology       Date:  2015-08-19       Impact factor: 9.910

2.  Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.

Authors:  Lutz Achtnichts; Otilia Obreja; Anna Conen; Christoph A Fux; Krassen Nedeltchev
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

Review 3.  Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Authors:  Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison
Journal:  Nat Rev Neurol       Date:  2016-11-25       Impact factor: 42.937

Review 4.  Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.

Authors:  Elena Grebenciucova; Anthony T Reder; Jacqueline T Bernard
Journal:  Mult Scler Relat Disord       Date:  2016-08-04       Impact factor: 4.339

5.  Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.

Authors:  Insun Chong; Kevin Yuqi Wang; Christie M Lincoln
Journal:  Clin Imaging       Date:  2018-11-14       Impact factor: 1.605

Review 6.  Fingolimod for relapsing-remitting multiple sclerosis.

Authors:  Loredana La Mantia; Irene Tramacere; Belal Firwana; Ilaria Pacchetti; Roberto Palumbo; Graziella Filippini
Journal:  Cochrane Database Syst Rev       Date:  2016-04-19

Review 7.  Disease-modifying treatments for multiple sclerosis - a review of approved medications.

Authors:  Ø Torkildsen; K-M Myhr; L Bø
Journal:  Eur J Neurol       Date:  2016-01       Impact factor: 6.089
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.